BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36582803)

  • 1. Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL.
    Lu Y; Li B; Huang H; Leng Q; Wang Q; Zhong R; Huang Y; Li C; Yuan R; Zhang Y
    Front Oncol; 2022; 12():1020317. PubMed ID: 36582803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Clinical-Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions.
    Jin P; Yang L; Qiao X; Hu C; Hu C; Wang X; Bao J
    Front Oncol; 2022; 12():840786. PubMed ID: 35280813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-Based Surrogate Imaging Markers of Aggressiveness in Prostate Cancer: Development of a Machine Learning Model Based on Radiomic Features.
    Dominguez I; Rios-Ibacache O; Caprile P; Gonzalez J; San Francisco IF; Besa C
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies.
    Zhang L; Zhang J; Tang M; Lei XY; Li LC
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
    Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
    Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer.
    Li H; Chen XL; Liu H; Lu T; Li ZL
    Front Oncol; 2022; 12():1087882. PubMed ID: 36686763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies.
    Qi Y; Zhang S; Wei J; Zhang G; Lei J; Yan W; Xiao Y; Yan S; Xue H; Feng F; Sun H; Tian J; Jin Z
    J Magn Reson Imaging; 2020 Jun; 51(6):1890-1899. PubMed ID: 31808980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
    Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
    Front Oncol; 2021; 11():825429. PubMed ID: 35155214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone.
    Zhao YY; Xiong ML; Liu YF; Duan LJ; Chen JL; Xing Z; Lin YS; Chen TH
    Front Oncol; 2023; 13():1247682. PubMed ID: 38074651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
    Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
    Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
    Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
    Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
    Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
    Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
    BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions.
    Brancato V; Aiello M; Basso L; Monti S; Palumbo L; Di Costanzo G; Salvatore M; Ragozzino A; Cavaliere C
    Sci Rep; 2021 Jan; 11(1):643. PubMed ID: 33436929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and external validation of a novel nomogram to predict prostate cancer in biopsy-naïve patients with PSA <10 ng/ml and PI-RADS v2.1 = 3 lesions.
    Hu C; Sun J; Xu Z; Zhang Z; Zhou Q; Xu J; Chen H; Wang C; Ouyang J
    Cancer Med; 2023 Feb; 12(3):2560-2571. PubMed ID: 35920264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer.
    Ma L; Zhou Q; Yin H; Ang X; Li Y; Xie G; Li G
    Transl Cancer Res; 2022 May; 11(5):1146-1161. PubMed ID: 35706813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
    Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
    Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
    Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
    J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
    Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
    Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.